Advertisement

Prognostische Parameter des Harnblasenkarzinoms

  • U. Engelmann
  • G. H. Jacobi
Conference paper
Part of the Fortschritte der Urologie und Nephrologie book series (2824, volume 19)

Zusammenfassung

Anhand des Krankengutes der Urologischen Klinik und Poliklinik der Universität Mainz von 1968 bis 1972 wurden prognostische Parameter erarbeitet, die im folgenden mit einer kurzen Literaturübersicht der letzten Jahre vorgestellt werden sollen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adolphs, H.D. und Steffens, L.: Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder. Urol. Res. 5/1: 29–33 (1977).PubMedCrossRefGoogle Scholar
  2. 2.
    Adolphs, H.D. und Steffens, L.: Correlation between tumor stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate. Eur. Urol. 3/1: 23–25 (1977).PubMedGoogle Scholar
  3. 3.
    Albert, L., Arndt, J., Hienzsch, E. und Kriester, A.: Probleme und Ergebnisse der kombinierten Behandlung maligner Harnblasentumoren im höheren Lebensalter. Z. Alternforsch. 32/2: 165–169 (1977).Google Scholar
  4. 4.
    Alsabti, E.A.K.: Serum alphafetoprotein in bladder carcinoma. Oncology 34/2: 78–79 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    Alsabti, E.A.K.: Prognostic value of urinary fibrinogen degradation products in bladder carcinoma. Eur. Surg. Res. 11/3: 185–190 (1979).PubMedCrossRefGoogle Scholar
  6. 6.
    Berlie, J., Janin, M.L., Hucher, M.: Mortalite par Cancer de la vessie en France. De 1952 a 1976. Son evolution croissante et sa repartition geographique particuliere dans le sud de la France. Cancer (Paris) 66/3: 317–326 (1979).Google Scholar
  7. 7.
    Bredael, J.J., Croker, B.P., und Glenn, J.F.: The curability of invasive bladder cancer treated by radical cystectomy. Eur. Urol. 6/4: 206–210 (1980).PubMedGoogle Scholar
  8. 8.
    Busch, C., Engberg, A., Norlen, B.J. und Stenkvist, B.: Malignancy grading of epithelial bladder tumours. Reproducibility of grading and comparison between forceps biopsy, aspiration biopsy and exfoliative cytology. Scand. J. Urol. Nephrol. 11/2: 143–148 (1977).PubMedCrossRefGoogle Scholar
  9. 9.
    Catalona, W.J., Smolev, J.K. und Harty, J.I.: Prognostic value of host immunocompetence in urologic cancer patients. J. Urol. (Baltimore) 114/6: 922–926 (1975).Google Scholar
  10. 10.
    Cowen, P.N.: False cytodiagnosis of bladder malignancy due to previous radiotherapy. Brit. J. Urol. 47/4: 405–412 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    Daughtry, J.D., Susan, L.P., Stewart, B.H. und Straffon, R.A.: Ileal conduit and cystectomy: a 10 year retrospective study of ileal conduits performed in conjunction with cystectomy and with a minimum 5 year follow up. J. Urol. 118/4: 556–557 (1977).PubMedGoogle Scholar
  12. 12.
    Denis, L., Nowe, P. und Declercq, G.: Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers. Eur. Urol. 118/4: 556–557 (1977).Google Scholar
  13. 13.
    De Voogt, H.J.: Value of urine cytology for early diagnosis of urothelial tumors (Germ). Die Bedeutung der Harnzytologie für die Frühdiagnose von Urotheltumoren. Therapiewoche 29/13: 2242–2245 (1979).Google Scholar
  14. 14.
    Duckett, J.W. Jr., Cromie, W.B. und Bongiovanni, A.M.: Genitourinary tumors in children. Semin. Oncol. 1/1: 71–75 (1974).PubMedGoogle Scholar
  15. 15.
    Elhilali, M.M., Brosman, S.A., Vescera, C.: The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer. Cancer (Philadelphia) 41/5: 1765–1770 (1978).CrossRefGoogle Scholar
  16. 16.
    Ellingwood, K.E., Drylie, D.M., De Ture, F.A. und Million, R.R.: Postdiversion precystectomy irradiation for cancer of the bladder. Cancer (Philadelphia) 43/3: 1032–1036 (1979).CrossRefGoogle Scholar
  17. 17.
    Esposti, P.L., Edsmyr, F. und Tribukait, B.: The role of exfoliative cytology in the management of bladder carcinoma. Urol. Res. 6/4: 197–200 (1978).PubMedCrossRefGoogle Scholar
  18. 18.
    Farrow, G.M., Utz, D.C., Rife, C.C. und Greene, L.F.: Clinical observations on sixty nine cases of in situ carcinoma of the urinary bladder. Cancer Res. 37/811; 2794–2798 (1977).PubMedGoogle Scholar
  19. 19.
    Flanagan, M.J. und Miller, A. III.: Evaluation of bladder washing cytology for bladder cancer surveillance. J. Urol. 119/1: 42–43 (1978).PubMedGoogle Scholar
  20. 20.
    Fleisher, M., Grabstald, H., Whitmore, W.F. Jr.: The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. J. Urol. 117/5: 635–637 (1977).PubMedGoogle Scholar
  21. 21.
    Fraser, R.A., Ravry, M.J., Segura, J.W. und Go, V.L.W.: Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer. J. Urol. (Baltimore) 114/2: 226–229 (1975).Google Scholar
  22. 22.
    Freni, S.C., Dalderup, L.M., Oudegeest, J.J. und Wensveen, N.: Erythrocyturia, Smoking and occupation. J. Clin. Path. 30/4: 341–344 (1977).PubMedCrossRefGoogle Scholar
  23. 23.
    Genster, H.G., Mommsen, S. und Hojsgaard, A.: Total cystectomy for bladder carcinoma (Germ). Totale Zystektomie bei Blasenkarzinom. Therapiewoche 29/13: 2204–2208 (1979).Google Scholar
  24. 24.
    Greiner, R., Zaunbauer, W., Skaleric, K. und Veraguth, P.: Lymphknotenmetastasen und Ureterobstruktion als prognostische Parameter der perkutanen Strahlentherapie des Harnblasenkarzinoms. Strahlentherapie 154/9: 617–621 (1978).PubMedGoogle Scholar
  25. 25.
    Haschek, H. und Studier, G.: Neue Aspekte in der Behandlung des Blasenkarzinoms im Alter Aktuel. Gerontol. 9/2: 53–58 (1979).Google Scholar
  26. 26.
    Jacobi, G.H., Jacobi-Hermanns, E. und Altwein, J.E.: Die Prognose des Harnblasenkarzinoms. Georg Thieme Verl. 1979 (Hrsg.).Google Scholar
  27. 27.
    Jacobi, G.H. und Altwein, J.E.: Divertikeltumoren der Harnblase. Analyse von 17 Beobachtungen. Aktuel. Urol. 8/5: 243–251 (1977).Google Scholar
  28. 28.
    Jakobsen, A., Bichel, P. und Sell, A.: Flow cytometric investigations of human bladder carcinoma compared to histological classification. Urol. Res. 7/2: 109–112 (1972).Google Scholar
  29. 29.
    Jakse, G. und Hofstaedter, F.: Further experiences with the specific red cell adherence test (SRCA) in bladder cancer. A histological and cytological study. Eur. Urol. 4/5: 356–360 (1978).PubMedGoogle Scholar
  30. 30.
    Kruglov, A.N. und Tomashevich, V.V.: 22: 147 (1956).Google Scholar
  31. 31.
    Lane, V.: Prognosis in carcinoma of the urachus. Eur. Urol. 2/6: 282–283 (1976).PubMedGoogle Scholar
  32. 32.
    Lange, P.H., Limas, C. und Fraley, E.E.: Tissue bloodgroup antigens and prognosis in low stags transitional cell carcinoma of the bladder. U. Urol. 11/1: 52–55 (1978).Google Scholar
  33. 33.
    Martinez-Pineiro, J.A., Muntanola, P. und Hidalgo, L.: Immunological evaluation in patients with urological cancers. Eur. Urol. 3/3: 159–162 (1977).PubMedGoogle Scholar
  34. 34.
    Martinez-Pineiro, J.A., Pertusa, C., Maganto, E.: Urinary fibrinogen degradation products (FDP) in bladder cancer. Eur. Urol. 4/5: 348–350 (1978).PubMedGoogle Scholar
  35. 35.
    Mauermayer, W., Tauber, R. und Steuer, G.: Epitheliale Harnblasentumoren im Kindesalter und beim Jugendlichen. Urologe Ausg. A 16/5: 286–289 (1977).Google Scholar
  36. 36.
    McCarron, J.P. und Marshall, V.F.: The survival of patients with bladder tumors treated by surgery: Comparative results of an old and a recent series. J. Urol. 122/3: 322–324 (1979).PubMedGoogle Scholar
  37. 37.
    McCarthy, J.P., Gavrell, G.J. und Le Blanc, G.A.: Transitional cell carcinoma of bladder in patients under thirty years of age. Urology 13/5: 487–489 (1979).PubMedCrossRefGoogle Scholar
  38. 38.
    Mihatsch, M.J., Rist, M., Romppanen, T., und Rutishauser, F.: Prognostic significance of peritumoural inflammation in invasive urothelial bladder carcinoma. Urol Res. 7/2: 97–102 (1979).PubMedCrossRefGoogle Scholar
  39. 39.
    Miller, C.T., Neutel, C.I., Nair, R.C.: Relative imprtance of risk factors in bladder carcinogenesis. J. Chronic Dis. 31/1: 51–56 (1978).PubMedCrossRefGoogle Scholar
  40. 40.
    Motomiya, Y., Ohzono, S., Shiomi, T.: Studies on lactic dehydrogenase of patients with urinary bladder tumors. I. Urinary lactic dehydrogenase. Invest. Urol. 17/2: 120–124 (1979).PubMedGoogle Scholar
  41. 41.
    Motomiya, Y., Yamada, K., Matsushima, S.: Studies on urinary isozymes of lactic dehydrogenase and betaglucuronidase in patients with bladder tumors. Urol. Res. 3/1: 41–48 (1975).PubMedCrossRefGoogle Scholar
  42. 42.
    Orandi, A. und Orandi, M.: Urine cytology in the detection of bladder tumor recurrence. J. Urol. (Baltimore) 116/5: 568–569 (1976).Google Scholar
  43. 43.
    Orjasaeter, H., Fossa, S.D., Schjolseth, S.A. und Fjaestad, K.: Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra. Cancer (Philadelphia) 42/1: 287–295 (1978).CrossRefGoogle Scholar
  44. 44.
    Page, B.H., Levison, V.B. und Curwen, M.P.: The site of recurrence of non-infiltrating bladder tumors. Br. J. Urol. 50/4: 237–242 (1978).PubMedCrossRefGoogle Scholar
  45. 45.
    Prout, G.R. Jr., Cox, C.E., Cummings, K.B.: Cytology and histopathology fo bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A. Cancer Res. 37/811; 2911–2915 (1977).Google Scholar
  46. 46.
    Prout, G.R. Jr., Griffin, P.P. und Shipley, W.U.: Bladder carcinoma as a systemic disease. Cancer (Philadelphia) 43/6: 2532–2539 (1979).CrossRefGoogle Scholar
  47. 47.
    Rehn, L.: Arch. Klin. Chir. 50: 588–600 (1895).Google Scholar
  48. 48.
    Richie, J.P., Blute, R.D. Jr. und Waisman, J.: Immunologic indicators of prognosis in bladder cancer; The importance of cell suface antigens. U. Urol. 123/1: 22–24 (1980).Google Scholar
  49. 49.
    Richie, J.P., Skinner, D.G. und Kaufmann, J.J.: Radical cystectomy for carcinoma of the bladder: 16 years of experience. J. Urol. (Baltimore) 113/2: 186–189 (1975).Google Scholar
  50. 50.
    Sandberg, A.A.: Chromosome markers and progression in bladder cancer. Cancer Res. 37/811: 2950–2956 (1977).PubMedGoogle Scholar
  51. 51.
    Sarma, K.P.: Tumours of the Urinary Bladder. Butterworths, London (Hrsg.) 1969.Google Scholar
  52. 52.
    Schellhammer, P.F., Bean, M.A. und Whitemore, W.F. Jr.: Prostatic involvement by transitional cell carcinoma: Pathogenesis, patterns and prognosis. J. Urol. 118/3: 399–403 (1977).PubMedGoogle Scholar
  53. 53.
    Seemayer, T.A., Knaack, J., Thelmo, W.L.: Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Cancer (Philad.) 36/2: 514–520 (1965).CrossRefGoogle Scholar
  54. 54.
    Suprun, H. und Bitterman, W.: A correlative cytohistologie study on the interrelationship between exfoliated urinary bladder carcinoma cell types and the staging and grading of these tumors. Acta Cytol. (Balt.) 19/3: 265–273 (1975).Google Scholar
  55. 55.
    Turner, A.G., Carter, S., Higgins, E.: The clinical diagnostic value of the carcinoembryonic antigen (CEA) in haematuria. Brit. J. Urol. 49/1: 61–66 (1977).PubMedCrossRefGoogle Scholar
  56. 56.
    Varkarakis, M.J., Gaeta, J., Moore, R.H. und Murphy, G.P.: Prognosis of bladder carcinoma in patients treated with cystectomy. Int. Urol. Nephrol. (Budap.) 7/1: 39–48 (1975).CrossRefGoogle Scholar
  57. 57.
    Wahren, B., Edsmyr, F. und Zimmerman, R.: Measurement of urinary CEA like substance. An aid in management of patients with bladder carcinoma. Cancer (Philad.) 36/4: 1490–1495 (1975).CrossRefGoogle Scholar
  58. 58.
    Weaver, P.C., Learmonth, I.D., Thomas, T.L.: Advanced bladder carcinoma treated by cystectomy: A report on twenty-three years experience (with special reference to salvage cystectomy following radical radiotherapy). Clin. Oncol. 5/1: 3–9 (1979).PubMedGoogle Scholar
  59. 59.
    Williams, G. und Castro, J.E.: The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer. Brit. J. Urol. 47/1: 97–101 (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1982

Authors and Affiliations

  • U. Engelmann
    • 1
  • G. H. Jacobi
    • 1
  1. 1.Urologische Klinik und Poliklinik der UniversitätMainzGermany

Personalised recommendations